Fujimori Juichi, Nakashima Ichiro, Baba Toru, Meguro Yuko, Ogawa Ryo, Fujihara Kazuo
Department of Neurology, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
Department of Behavioral Neurology and Cognitive Neuroscience, Tohoku University Graduate School of Medicine, Sendai, Japan.
eNeurologicalSci. 2017 Sep 21;9:3-7. doi: 10.1016/j.ensci.2017.09.001. eCollection 2017 Dec.
Approximately 55% of patients with neuromyelitis optica spectrum disorder (NMOSD) show cognitive impairment as evaluated using the Rao Brief Repeatable Neuropsychological Battery (BRBN), but this frequency appears to be higher than the frequency of specific brain lesions in NMOSD.
We studied whether cognitive impairment could be observed in NMOSD patients with no or minor non-specific brain lesions.
We evaluated cognitive function in 12 NMOSD and 14 MS patients using the Wechsler Adult Intelligence Scale-III (WAIS-III), the Wechsler Memory Scale-Revised (WMS-R), and the BRBN. We judged as cognitively impaired patients whose scores were below the average by 2 standard deviations or greater in 2 or more cognitive domains.
Cognitive impairment was observed in 5 MS patients (35.7%) and in the only NMOSD patient (8.3%) with symptomatic brain lesions, but not in the other NMOSD patients who had no or minor non-specific brain lesions. Meanwhile, 5 NMOSD (41.7%) and 4 MS (28.6%) patients who had normal cognition according to the WAIS-III and WMS-R were assessed as cognitively impaired by the BRBN (which is not standardized for age).
Cognitive function in NMOSD patients with no or mild non-specific brain lesions was preserved according to the WAIS-III and WMS-R.
使用Rao简明可重复神经心理成套测验(BRBN)评估时,约55%的视神经脊髓炎谱系障碍(NMOSD)患者存在认知障碍,但这一频率似乎高于NMOSD中特定脑病变的频率。
我们研究了在无或仅有轻微非特异性脑病变的NMOSD患者中是否能观察到认知障碍。
我们使用韦氏成人智力量表第三版(WAIS-III)、韦氏记忆量表修订版(WMS-R)和BRBN对12例NMOSD患者和14例多发性硬化(MS)患者的认知功能进行了评估。我们将在2个或更多认知领域得分低于平均水平2个标准差或更多的患者判定为认知受损。
在有症状性脑病变的5例MS患者(35.7%)和仅1例NMOSD患者(8.3%)中观察到了认知障碍,但在其他无或仅有轻微非特异性脑病变的NMOSD患者中未观察到。同时,根据WAIS-III和WMS-R认知正常的5例NMOSD患者(41.7%)和4例MS患者(28.6%)被BRBN评估为认知受损(BRBN未按年龄标准化)。
根据WAIS-III和WMS-R,无或仅有轻度非特异性脑病变的NMOSD患者的认知功能得以保留。